Megan R. Haymart, MD
Megan Haymart, MD, is Assistant Professor of Medicine in the Division of Metabolism, Endocrinology, and Diabetes (MEND) and Hematology/Oncology. Dr. Haymart completed her medical school and internal medicine residency at Johns Hopkins and prior to her arrival at University of Michigan she went on to complete endocrinology fellowship and two years as faculty at the University of Wisconsin. Dr. Haymartís research interest is in the role of patient, provider, and health system factors in the diagnosis and management of thyroid cancer.
Selected Key Papers
- Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ. Use of radioactive iodine for thyroid cancer. JAMA, 2011;306(7):721-728. PMCID: PMC3352591
- Haymart MR, Muenz D, Stewart AK, Griggs JJ, Banerjee M. Disease severity and radioactive iodine use for thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 2013;98(2):678-686.
- Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer. Cancer, 2013;119(2): 259-265. PMCID: PMC3465617
- Papaleontiou M, Banerjee M, Yang D, Sisson J, Koenig R, Haymart MR. Factors that influence radioactive iodine use for thyroid cancer. Thyroid, 2013;23(2):219-224. PMCID: PMC3569922
- Haymart MR, Banerjee M, Yang D, Stewart AK, Sisson JC, Koenig RJ, Doherty GM, Griggs JJ. Variation in the management of thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 2013;98(5):2001-8.
- Haymart MR, Banerjee M, Yang D, Stewart AK, Doherty GM, Koenig RJ, Griggs JJ. The relationship between extent of thyroid cancer surgery and use of radioactive iodine. Annals of Surgery, 2013;258(2):354-8.